PLAINSBORO, N.J., Sept. 16, 2007 — Integra LifeSciences Holdings Corporation today announced that Integra NeuroSciences has received 510 clearance from the United States Food and Drug Administration to market the DuraGen XS Dural Regeneration Matrix in the United States.
More: continued here
